Cargando…

Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose

BACKGROUND: Diabetes is a risk factor for respiratory infection, and hyperglycaemia is associated with increased glucose in airway surface liquid and risk of Staphylococcus aureus infection. OBJECTIVES: To investigate whether elevation of basolateral/blood glucose concentration promotes airway Staph...

Descripción completa

Detalles Bibliográficos
Autores principales: Garnett, James P, Baker, Emma H, Naik, Sonam, Lindsay, Jodi A, Knight, Gwenan M, Gill, Simren, Tregoning, John S, Baines, Deborah L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756442/
https://www.ncbi.nlm.nih.gov/pubmed/23709760
http://dx.doi.org/10.1136/thoraxjnl-2012-203178
_version_ 1782282098740035584
author Garnett, James P
Baker, Emma H
Naik, Sonam
Lindsay, Jodi A
Knight, Gwenan M
Gill, Simren
Tregoning, John S
Baines, Deborah L
author_facet Garnett, James P
Baker, Emma H
Naik, Sonam
Lindsay, Jodi A
Knight, Gwenan M
Gill, Simren
Tregoning, John S
Baines, Deborah L
author_sort Garnett, James P
collection PubMed
description BACKGROUND: Diabetes is a risk factor for respiratory infection, and hyperglycaemia is associated with increased glucose in airway surface liquid and risk of Staphylococcus aureus infection. OBJECTIVES: To investigate whether elevation of basolateral/blood glucose concentration promotes airway Staphylococcus aureus growth and whether pretreatment with the antidiabetic drug metformin affects this relationship. METHODS: Human airway epithelial cells grown at air–liquid interface (±18 h pre-treatment, 30 μM–1 mM metformin) were inoculated with 5×10(5) colony-forming units (CFU)/cm(2) S aureus 8325-4 or JE2 or Pseudomonas aeruginosa PA01 on the apical surface and incubated for 7 h. Wild-type C57BL/6 or db/db (leptin receptor-deficient) mice, 6–10 weeks old, were treated with intraperitoneal phosphate-buffered saline or 40 mg/kg metformin for 2 days before intranasal inoculation with 1×10(7) CFU S aureus. Mice were culled 24 h after infection and bronchoalveolar lavage fluid collected. RESULTS: Apical S aureus growth increased with basolateral glucose concentration in an in vitro airway epithelia–bacteria co-culture model. S aureus reduced transepithelial electrical resistance (R(T)) and increased paracellular glucose flux. Metformin inhibited the glucose-induced growth of S aureus, increased R(T) and decreased glucose flux. Diabetic (db/db) mice infected with S aureus exhibited a higher bacterial load in their airways than control mice after 2 days and metformin treatment reversed this effect. Metformin did not decrease blood glucose but reduced paracellular flux across ex vivo murine tracheas. CONCLUSIONS: Hyperglycaemia promotes respiratory S aureus infection, and metformin modifies glucose flux across the airway epithelium to limit hyperglycaemia-induced bacterial growth. Metformin might, therefore, be of additional benefit in the prevention and treatment of respiratory infection.
format Online
Article
Text
id pubmed-3756442
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-37564422013-08-30 Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose Garnett, James P Baker, Emma H Naik, Sonam Lindsay, Jodi A Knight, Gwenan M Gill, Simren Tregoning, John S Baines, Deborah L Thorax Respiratory Infection BACKGROUND: Diabetes is a risk factor for respiratory infection, and hyperglycaemia is associated with increased glucose in airway surface liquid and risk of Staphylococcus aureus infection. OBJECTIVES: To investigate whether elevation of basolateral/blood glucose concentration promotes airway Staphylococcus aureus growth and whether pretreatment with the antidiabetic drug metformin affects this relationship. METHODS: Human airway epithelial cells grown at air–liquid interface (±18 h pre-treatment, 30 μM–1 mM metformin) were inoculated with 5×10(5) colony-forming units (CFU)/cm(2) S aureus 8325-4 or JE2 or Pseudomonas aeruginosa PA01 on the apical surface and incubated for 7 h. Wild-type C57BL/6 or db/db (leptin receptor-deficient) mice, 6–10 weeks old, were treated with intraperitoneal phosphate-buffered saline or 40 mg/kg metformin for 2 days before intranasal inoculation with 1×10(7) CFU S aureus. Mice were culled 24 h after infection and bronchoalveolar lavage fluid collected. RESULTS: Apical S aureus growth increased with basolateral glucose concentration in an in vitro airway epithelia–bacteria co-culture model. S aureus reduced transepithelial electrical resistance (R(T)) and increased paracellular glucose flux. Metformin inhibited the glucose-induced growth of S aureus, increased R(T) and decreased glucose flux. Diabetic (db/db) mice infected with S aureus exhibited a higher bacterial load in their airways than control mice after 2 days and metformin treatment reversed this effect. Metformin did not decrease blood glucose but reduced paracellular flux across ex vivo murine tracheas. CONCLUSIONS: Hyperglycaemia promotes respiratory S aureus infection, and metformin modifies glucose flux across the airway epithelium to limit hyperglycaemia-induced bacterial growth. Metformin might, therefore, be of additional benefit in the prevention and treatment of respiratory infection. BMJ Publishing Group 2013-09 2013-05-24 /pmc/articles/PMC3756442/ /pubmed/23709760 http://dx.doi.org/10.1136/thoraxjnl-2012-203178 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Respiratory Infection
Garnett, James P
Baker, Emma H
Naik, Sonam
Lindsay, Jodi A
Knight, Gwenan M
Gill, Simren
Tregoning, John S
Baines, Deborah L
Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose
title Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose
title_full Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose
title_fullStr Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose
title_full_unstemmed Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose
title_short Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose
title_sort metformin reduces airway glucose permeability and hyperglycaemia-induced staphylococcus aureus load independently of effects on blood glucose
topic Respiratory Infection
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756442/
https://www.ncbi.nlm.nih.gov/pubmed/23709760
http://dx.doi.org/10.1136/thoraxjnl-2012-203178
work_keys_str_mv AT garnettjamesp metforminreducesairwayglucosepermeabilityandhyperglycaemiainducedstaphylococcusaureusloadindependentlyofeffectsonbloodglucose
AT bakeremmah metforminreducesairwayglucosepermeabilityandhyperglycaemiainducedstaphylococcusaureusloadindependentlyofeffectsonbloodglucose
AT naiksonam metforminreducesairwayglucosepermeabilityandhyperglycaemiainducedstaphylococcusaureusloadindependentlyofeffectsonbloodglucose
AT lindsayjodia metforminreducesairwayglucosepermeabilityandhyperglycaemiainducedstaphylococcusaureusloadindependentlyofeffectsonbloodglucose
AT knightgwenanm metforminreducesairwayglucosepermeabilityandhyperglycaemiainducedstaphylococcusaureusloadindependentlyofeffectsonbloodglucose
AT gillsimren metforminreducesairwayglucosepermeabilityandhyperglycaemiainducedstaphylococcusaureusloadindependentlyofeffectsonbloodglucose
AT tregoningjohns metforminreducesairwayglucosepermeabilityandhyperglycaemiainducedstaphylococcusaureusloadindependentlyofeffectsonbloodglucose
AT bainesdeborahl metforminreducesairwayglucosepermeabilityandhyperglycaemiainducedstaphylococcusaureusloadindependentlyofeffectsonbloodglucose